Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02147483 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT02147483: Completed NA study, sponsored by University of Virginia.

NCT02147483 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02147483, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

We propose to conduct a pilot study that will examine the utility and mechanisms of Mindfulness-Based Relapse Prevention in reducing alcohol consumption, relapse rates, and physiological arousal to stress in adults 21 years of age and older who have met DSM-IV-TR diagnostic criteria for alcohol dependence within the past year but have abstained from drinking for the last thirty days. MBRP is designed to improve one's ability to self-regulate emotions, thoughts and physical states, thus reducing the need to alleviate associated discomfort through substance use. Participants assigned to the intervention group will receive an 8-week training course of MBRP over a period of nine weeks; participants assigned to the Treatment As Usual (TAU) group will continue treatment as usual, which includes utilizing their own effective strategies to refrain from alcohol use. All participants will be assessed for pretreatment severity of psychological abuse/trauma as well as pre and posttreatment psychosocial functioning (e.g., alcohol consumption, symptoms of depression and anxiety, emotion regulation/coping). The outcome of treatment will be evaluated using a) Timeline Followback drinking data and b) self-report ratings of acquisition of MBRP skills (e.g., state/trait mindfulness, acceptance and awareness, and perceived stress) and depressive and anxiety symptom severity. We hypothesize that participants who receive MBRP training will demonstrate greater acceptance and awareness, reduced cravings, and have a lower likelihood of relapse than participants in the TAU group. It is also expected that MBRP participants will demonstrate greater improvements on psychological measures of depression, anxiety, emotion regulation and coping, and show less perceived stress and physiological arousal to stress compared to TAU participants. Finally, little is known about which types of individuals are most likely to benefit from MBRP. Thus, secondary analyses will help to clarify for whom MBRP may

Primary Outcome

Difference scores on mindfulness scales (session 04 minus baseline, session 08 minus baseline, two-month follow-up minus baseline, four-month follow-up minus baseline) will be calculated. 2 group (intervention, TAU) x 5 interval (baseline, session 04, session 08, two-months follow-up, four-months follow-up) repeated measures analyses of variance (ANOVAs) will be conducted.

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Mindfulness Based Relapse Prevention

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2012-08
Est. Completion 2018-01
Phase NA
University of Virginia

449 total trials

What the finished NCT02147483 record still lists

NCT02147483 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.

NCT02147483 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02147483 about?

NCT02147483 is a clinical study titled "Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission". We propose to conduct a pilot study that will examine the utility and mechanisms of Mindfulness-Based Relapse Prevention in reducing alcohol consumption, relapse rates, and physiological arousal to stress in adults 21 years of age and older who have met DSM-IV-TR diagnostic criteria for alcohol depe...

What is the current status of trial NCT02147483?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2012-08. Estimated completion is 2018-01.

What interventions are being tested in trial NCT02147483?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Mindfulness Based Relapse Prevention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02147483?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02147483's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02147483, the US trial registry maintained by the National Library of Medicine. NCT02147483 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.